OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Long View on COVID-19 Theranostics and Oral Antivirals: Living with Endemic Disease and Lessons from Molnupiravir
Anmar Al‐Taie, Fatma Rana Denkdemir, Zaineb Sharief, et al.
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 6, pp. 324-328
Closed Access | Times Cited: 13
Anmar Al‐Taie, Fatma Rana Denkdemir, Zaineb Sharief, et al.
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 6, pp. 324-328
Closed Access | Times Cited: 13
Showing 13 citing articles:
Oral antiviral treatments for COVID-19: opportunities and challenges
Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1255-1278
Open Access | Times Cited: 71
Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1255-1278
Open Access | Times Cited: 71
Assessment of acceptance, concerns and side effects towards COVID-19 vaccination among the community: A cross-sectional study from Baghdad, Iraq
Zahraa Albasry, Anmar Al‐Taie
Clinical Epidemiology and Global Health (2023) Vol. 20, pp. 101217-101217
Open Access | Times Cited: 14
Zahraa Albasry, Anmar Al‐Taie
Clinical Epidemiology and Global Health (2023) Vol. 20, pp. 101217-101217
Open Access | Times Cited: 14
Simultaneous Electrochemical Quantification of Favipiravir and Molnupiravir as Antiviral Drugs for the Treatment of COVID-19 by Using a Glassy Carbon Electrode Modified by Pd/Co-Mn-MOF-74
Ehsan Mahdavi Nejad
Journal of The Electrochemical Society (2024) Vol. 171, Iss. 1, pp. 017502-017502
Closed Access | Times Cited: 5
Ehsan Mahdavi Nejad
Journal of The Electrochemical Society (2024) Vol. 171, Iss. 1, pp. 017502-017502
Closed Access | Times Cited: 5
Nanotechnology and COVID-19 Convergence: Toward New Planetary Health Interventions Against the Pandemic
Panchanan Sahoo, Jyotirmayee Dey, Soumya Ranjan Mahapatra, et al.
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 9, pp. 473-488
Closed Access | Times Cited: 21
Panchanan Sahoo, Jyotirmayee Dey, Soumya Ranjan Mahapatra, et al.
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 9, pp. 473-488
Closed Access | Times Cited: 21
VV116 as a potential treatment for COVID-19
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 6, pp. 675-678
Closed Access | Times Cited: 7
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 6, pp. 675-678
Closed Access | Times Cited: 7
Six Pivotal Lessons Learned in South Korea for Whole-of-Government Approach to Successful COVID-19 Vaccine Rollout in Planetary Health
Shinae Hong
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 10, pp. 567-579
Closed Access | Times Cited: 7
Shinae Hong
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 10, pp. 567-579
Closed Access | Times Cited: 7
Theranostics for COVID-19 Antiviral Drugs: Prospects and Challenges for Worldwide Precision/Personalized Medicine
Caíque Manóchio, Sabrina Torres-Loureiro, Mariana M. Scudeler, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 27, Iss. 1, pp. 6-14
Closed Access | Times Cited: 3
Caíque Manóchio, Sabrina Torres-Loureiro, Mariana M. Scudeler, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 27, Iss. 1, pp. 6-14
Closed Access | Times Cited: 3
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: Hope, hype and reality
Anmar Al‐Taie, Ayşe Şeyma Büyük, Semra Şardaş
Pulmonary Pharmacology & Therapeutics (2022) Vol. 77, pp. 102172-102172
Open Access | Times Cited: 5
Anmar Al‐Taie, Ayşe Şeyma Büyük, Semra Şardaş
Pulmonary Pharmacology & Therapeutics (2022) Vol. 77, pp. 102172-102172
Open Access | Times Cited: 5
Will Omics Biotechnologies Save Us from Future Pandemics? Lessons from COVID-19 for Vaccinomics and Adversomics
Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2022) Vol. 11, Iss. 1, pp. 52-52
Open Access | Times Cited: 2
Alessandra Ferraresi, Ciro Isidoro
Biomedicines (2022) Vol. 11, Iss. 1, pp. 52-52
Open Access | Times Cited: 2
Role of Molnupiravir in the Treatment of COVID-19
Aman Sharma, Vaishali M. Patil, Meenakshi Dahiya, et al.
Anti-Infective Agents (2023) Vol. 21, Iss. 4
Closed Access
Aman Sharma, Vaishali M. Patil, Meenakshi Dahiya, et al.
Anti-Infective Agents (2023) Vol. 21, Iss. 4
Closed Access
Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog
Gerald H. Lushington, Annika Linde, Tonatiuh Melgarejo
BioTech (2023) Vol. 12, Iss. 4, pp. 61-61
Open Access
Gerald H. Lushington, Annika Linde, Tonatiuh Melgarejo
BioTech (2023) Vol. 12, Iss. 4, pp. 61-61
Open Access
Call for Papers: COVID-19 Systems Biology, Multi-Omics Integration, and Digital Technologies in Ecology, Health, and Society
Vural Özdemir
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 9, pp. 471-472
Closed Access
Vural Özdemir
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 9, pp. 471-472
Closed Access
Natural Compounds for COVID-19 Antiviral Drug Discovery
Nicholas Ekow Thomford
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 10, pp. 580-581
Closed Access
Nicholas Ekow Thomford
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 10, pp. 580-581
Closed Access
